top of page

The SeroDop Theory

Join me in a journey to reclassify Mental Health Disorders based on an initial two-axis map incorporating dopaminergic and serotonergic systems to enhance pharmacological interventions

A randomized, double-blind, placebo-controlled trial investigating the effect of methylphenidate on Patient Health Questionnaire-9 (PHQ9) responses in patients with Major Depressive Disorder (MDD)

If you are a clinician, an academic supervisor or have general interest in partnering in this study fill the form on this page.


Neurobiological alternative for DSM-5

Implementing a neurobiological framework for classifying mental health disorders, such as major depressive disorder (MDD), generalized anxiety disorder (GAD), and attention deficit disorder (ADD), offers significant potential for tailored pharmacological interventions.

Methylphenidate Molecule_edited.jpg

Let's collaborate

Thanks for submitting!

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
bottom of page